Shares of Catalent Inc (NASDAQ:CTLT) have been assigned a consensus rating of “Hold” from the seven analysts that are currently covering the company. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and three have given a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $28.67.
A number of equities research analysts have commented on the stock. Jefferies Group restated a “hold” rating and set a $28.00 target price (up previously from $25.00) on shares of Catalent in a research note on Thursday, September 29th. Morgan Stanley restated a “hold” rating on shares of Catalent in a research note on Tuesday, August 30th. Wells Fargo & Co. upgraded shares of Catalent from a “market perform” rating to an “outperform” rating in a research note on Tuesday, June 21st. Zacks Investment Research upgraded shares of Catalent from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 5th. Finally, Piper Jaffray Cos. restated an “overweight” rating and set a $30.00 target price (down previously from $30.50) on shares of Catalent in a research note on Tuesday, August 30th.
In other news, major shareholder Blackstone Management Associat sold 17,100,705 shares of Catalent stock in a transaction that occurred on Friday, September 9th. The shares were sold at an average price of $23.58, for a total transaction of $403,234,623.90. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Large investors have recently added to or reduced their stakes in the stock. Pacer Advisors Inc. bought a new stake in Catalent during the second quarter valued at about $102,000. Barclays PLC raised its position in Catalent by 406.7% in the second quarter. Barclays PLC now owns 5,275 shares of the company’s stock worth $121,000 after buying an additional 4,234 shares during the period. Emerald Acquisition Ltd. acquired a new position in Catalent during the second quarter worth $123,000. LS Investment Advisors LLC raised its position in Catalent by 85.2% in the second quarter. LS Investment Advisors LLC now owns 7,131 shares of the company’s stock worth $164,000 after buying an additional 3,280 shares during the period. Finally, Tower Research Capital LLC TRC acquired a new position in Catalent during the second quarter worth $196,000.
Shares of Catalent (NASDAQ:CTLT) opened at 25.68 on Tuesday. The stock has a market cap of $3.20 billion and a PE ratio of 28.85. The stock has a 50 day moving average of $25.36 and a 200-day moving average of $25.67. Catalent has a 52 week low of $18.92 and a 52 week high of $32.24.
Catalent (NASDAQ:CTLT) last issued its quarterly earnings data on Monday, August 29th. The company reported $0.52 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.53 by $0.01. The firm had revenue of $532.20 million for the quarter. During the same period in the previous year, the firm posted $0.61 EPS. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. Equities research analysts predict that Catalent will post $1.40 earnings per share for the current fiscal year.
Catalent Company Profile
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.
Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with MarketBeat.com's FREE daily email newsletter.